| Perspectives for cancer prevention with natural compounds ARMR Amin, O Kucuk, FR Khuri, DM Shin Journal of clinical oncology 27 (16), 2712-2725, 2009 | 773 | 2009 |
| Cancer prevention with natural compounds NP Gullett, ARMR Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, ... Seminars in oncology 37 (3), 258-281, 2010 | 618 | 2010 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 325 | 2015 |
| New perspectives of curcumin in cancer prevention W Park, ARMR Amin, ZG Chen, DM Shin Cancer prevention research 6 (5), 387-400, 2013 | 319 | 2013 |
| Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells AA Thant, A Nawa, F Kikkawa, Y Ichigotani, Y Zhang, TT Sein, ... Clinical & experimental metastasis 18, 423-428, 2000 | 212 | 2000 |
| Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity D Majumdar, KH Jung, H Zhang, S Nannapaneni, X Wang, ARMR Amin, ... Cancer prevention research 7 (1), 65-73, 2014 | 183 | 2014 |
| Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds ARMR Amin, PA Karpowicz, TE Carey, J Arbiser, R Nahta, ZG Chen, ... Seminars in cancer biology 35, S55-S77, 2015 | 170 | 2015 |
| Secretion of matrix metalloproteinase‐9 by the proinflammatory cytokine, IL‐1β: a role for the dual signalling pathways, Akt and Erk ARM Ruhul Amin, T Senga, ML Oo, AA Thant, M Hamaguchi Genes to Cells 8 (6), 515-523, 2003 | 145 | 2003 |
| Enhanced anti-tumor activity by the combination of the natural compounds (−)-epigallocatechin-3-gallate and luteolin: potential role of p53 ARMR Amin, D Wang, H Zhang, S Peng, HJC Shin, JC Brandes, ... Journal of Biological Chemistry 285 (45), 34557-34565, 2010 | 139 | 2010 |
| SHPS-1, a multifunctional transmembrane glycoprotein K Oshima, ARMR Amin, A Suzuki, M Hamaguchi, S Matsuda FEBS letters 519 (1-3), 1-7, 2002 | 138 | 2002 |
| RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy MA Rahman, ARMR Amin, D Wang, L Koenig, S Nannapaneni, Z Chen, ... Clinical cancer research 19 (13), 3416-3428, 2013 | 131 | 2013 |
| Chemoprevention of head and neck cancer with green tea polyphenols JW Kim, ARMR Amin, DM Shin Cancer Prevention Research 3 (8), 900-909, 2010 | 119 | 2010 |
| A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and-9 TT Sein, AA Thant, Y Hiraiwa, ARM Amin, Y Sohara, Y Liu, S Matsuda, ... Oncogene 19 (48), 5539-5542, 2000 | 106 | 2000 |
| Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth MA Rahman, ARMR Amin, X Wang, JE Zuckerman, CHJ Choi, B Zhou, ... Journal of Controlled Release 159 (3), 384-392, 2012 | 103 | 2012 |
| Chemopreventive potential of natural compounds in head and neck cancer MA Rahman, ARMR Amin, DM Shin Nutrition and cancer 62 (7), 973-987, 2010 | 81 | 2010 |
| DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation K Hastak, RK Paul, MK Agarwal, VS Thakur, ARMR Amin, S Agrawal, ... Proceedings of the National Academy of Sciences 105 (17), 6314-6319, 2008 | 81 | 2008 |
| Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds A Haque, D Brazeau, AR Amin European Journal of Cancer 149, 165-183, 2021 | 74 | 2021 |
| Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies DM Shin, H Zhang, NF Saba, AY Chen, S Nannapaneni, ARMR Amin, ... Clinical Cancer Research 19 (5), 1244-1256, 2013 | 73 | 2013 |
| p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG VS Thakur, ARMR Amin, RK Paul, K Gupta, K Hastak, MK Agarwal, ... Cancer letters 296 (2), 225-232, 2010 | 73 | 2010 |
| Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-κB ARMR Amin, FR Khuri, Z Chen, DM Shin Cancer Prevention Research 2 (6), 538-545, 2009 | 73 | 2009 |
